BIO.AX

Biome Australia Limited BIO.AX

BIO.AX
Biome Australia Limited ILA.AX
Island Pharmaceuticals Limited ALA.AX
Arovella Therapeutics Limited ACW.AX
Actinogen Medical Limited IMU.AX
Imugene Limited SPL.AX
Starpharma Holdings Limited RAD.AX
Radiopharm Theranostics Limited EZZ.AX
EZZ Life Science Holdings Limited ATH.AX
Alterity Therapeutics Limited RCE.AX
Recce Pharmaceuticals Ltd

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BIO.AX ILA.AX ALA.AX ACW.AX IMU.AX SPL.AX RAD.AX EZZ.AX ATH.AX RCE.AX
6M 4.49 % 124.24 % 21.79 % 3.45 % -54.75 % 187.88 % 76.19 % 71.52 % 33.33 % 45.61 %
YTD -22.50 % 124.24 % -44.12 % 15.38 % -69.92 % 159.09 % 54.17 % -9.06 % 33.33 % -15.31 %
1Y -30.60 % 111.43 % -50.00 % 11.11 % -76.05 % 200.00 % 42.31 % -32.42 % 300.00 % -23.85 %
3Y 511.84 % 134.38 % 227.59 % -72.46 % -93.08 % -55.81 % -75.44 % 788.52 % -7.69 % -36.49 %
5Y 287.50 % -24.10 % 131.71 % 29.25 % -78.61 % -80.87 % -89.63 % 133.62 % -75.00 % -60.85 %
10Y 287.50 % -24.10 % -82.24 % -48.71 % 31.89 % -60.42 % -89.63 % 133.62 % -90.40 % 39.71 %
From the beginning 287.50 % -24.10 % -97.10 % -95.44 % -99.52 % -66.47 % -89.63 % 133.62 % -97.60 % 39.71 %

Dividend

EZZ Life Science Holdings Limited